# A Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host Disease

> **NCT03605940** · PHASE2 · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 78 (estimated)

## Conditions studied

- Acute-graft-versus-host Disease

## Interventions

- **COMBINATION_PRODUCT:** Methoxsalen + ECP device
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT03605940
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03605940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03605940, "A Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host Disease". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03605940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*